Get started
V.F. Corporation (VFC) (For Study Purpose Only)Entry Price Range: $20 - $22 Stop Loss (SL): $15.35 Portfolio Allocation: 1% of the portfolio Risk Level: High Rationale: Attractive Entry Point: The suggested price range provides a potential value zone in the stock. Risk Management: Strict stop-loss placement at $15.35 limits downside exposure. Portfolio Allocation: Keeping the position size at 1% reflects the high-risk nature of the trade, minimizing overall portfolio impact. Disclaimer This recommendation is for educational purposes only. Always consult your financial advisor before making any investment decisions. Stock trading involves risks, including the potential loss of capital. Ensure to evaluate your risk tolerance and conduct thorough research.
NYSE:VFCLong
by KSLBroking
Can Market Turbulence Create Future Innovation?In a dramatic turn of events that sent shockwaves through the pharmaceutical industry, Novo Nordisk's recent setback with its experimental obesity drug CagriSema presents a fascinating case study in market resilience and scientific progress. The company's stock plummeted 24% after trial results showed a 22.7% weight reduction efficacy, falling short of the anticipated 25% target. Yet, beneath this apparent disappointment lies a deeper story of pharmaceutical innovation and market adaptation. The obesity treatment landscape stands at a pivotal crossroads, with the market experiencing exponential growth from its modest beginnings to a staggering $24 billion industry in 2023. Novo Nordisk's journey, alongside competitor Eli Lilly, exemplifies how setbacks often catalyze breakthrough innovations. The CagriSema trial, involving 3,400 participants, represents a clinical study and a testament to the industry's commitment to addressing global health challenges. Looking ahead, this moment of market recalibration might well be remembered as a turning point in the evolution of obesity treatment. With projections suggesting a potential $200 billion market by the early 2030s, the current turbulence could drive even greater innovation and competition. The fact that only 57% of trial participants reached the highest CagriSema dose points to untapped potential and future opportunities for optimization, suggesting that today's apparent setback might pave the way for tomorrow's breakthroughs.
NYSE:NVOShort
by UDIS_View
UNH Selloff Unreasonable - Still 15% ROI Short-TermSince my first NYSE:UNH idea a couple of days ago the price of this stock dropped significantly. If you've been part of the first idea you should've been able to lock in around 1.x% of return when using a tight stop-loss. Otherwise you've been stopped out with break-even. Nevertheless, the sell-off was not helpful and is completely exaggerating the situation at UNH since the company is not really effected by the current PBM debate. "Deutsche Bank sees a potential divestiture as not having a significant impact on earnings, estimating the risk at likely less than $200M of the company’s roughly $30B+ operating earnings. Deutsche Bank noted, however, that CVS (CVS), Cigna (CI) and UnitedHealth (NYSE:UNH) 'could face additional risk from losing the ability to vertically integrate the PBM, fulfillment and manufacturing functions of biosimilars through organizations like Cordavis and Quallent.' Despite concerns about the potential breakup of their pharmacy businesses, Deutsche Bank maintained it's buy rating on UnitedHealth (UNH)." From a technical standpoint we can see a confluence of support: Weekly SMA200 Strong Trendline from March 2020 Horizontal Support at $480 UNH managed to bounce from the trendline intraday today. This could mean we're going to see a turnaround from here. If we break below the trendline on the daily chart this trade will be invalidated. Otherwise our target sits at $550.
NYSE:UNHLong
by LGNDRY-Capital
1
D-Wave Quantum (QBTS) Analysis Company Overview: D-Wave Quantum NYSE:QBTS is a pioneer in commercial quantum computing, leveraging its annealing-based quantum technology to address complex computational challenges. Its first-mover advantage in quantum solutions positions it as a key player in this emerging industry. Key Catalysts: Differentiated Technology: D-Wave’s annealing-based quantum model sets it apart from competitors focused on gate-based systems, enabling practical, near-term solutions for optimization problems across industries. Government and Defense Partnerships: Increasing traction with key clients like the U.S. Department of Defense and other government agencies validates D-Wave’s credibility and enhances its potential for lucrative long-term contracts. Strong Revenue Projections: Wall Street forecasts a nearly 70% revenue growth to $14.8 million by 2025, reflecting rising demand for D-Wave’s quantum solutions and marking progress toward scalability and profitability. Investment Outlook: Bullish Outlook: We are bullish on QBTS above the $3.75-$3.80 range, supported by its competitive technology, increasing adoption, and strategic partnerships. Upside Potential: Our upside target for QBTS is $9.00-$10.00, driven by expanding commercial applications, strong revenue growth, and continued government traction. 🚀 QBTS—Harnessing Quantum Power to Solve Tomorrow’s Challenges Today. #QuantumComputing #Innovation #TechGrowth
NYSE:QBTSLong
by Richtv_official
META, MAJOR CORRECTION LIKELY SOON Hey guys I wanted to share what I’m seeing in meta on the 2 week. Meta is another one that’s had a very nice move for a while. I hope some of y’all did well on it. Meta is coming to the end of this phase and it’s due for a large correction very soon in my opinion. We have strong bearish divergence between price action, strength, and volume combined. Also hitting a major trend line. It’s in the final stages of wave 5 now. The rsi is finally about ready to rollover as well. Over the coming weeks and months ahead we are looking at a potential 35% correction from here for Meta. Of course there will be some nice swing trading in the middle of all this which is what we do at THE TRADER EDGE. I still wanted to start sharing the bigger pic ideas with the public in hopes that I can truly add a little value to someone out there. As traders we always trade the higher probabilities. Nothing is certain here with meta but the probabilities of at least a hard correction are very high. Stay safe, stay focused, no emotions. God bless y’all 👊🏼 Visit us at : thetraderedge.com
NASDAQ:METAShort
by Thetraderedge
Coca-Cola Company (KO) - Long Setup After One More Leg DownWe're identifying a potential long setup on Coca-Cola's weekly chart. The price is moving towards a key buy zone near the 0.618 - 0.786 Fibonacci retracement levels, a strong area of historical support. This setup indicates a favorable risk-to-reward ratio for a bullish rebound. Trade Details: - Entry (Buy Zone): $59.88 - Stop-loss: $57.15 Targets: - Target 1: $65.12 (0.382 retracement) - Target 2: $78.82 (0.236 retracement) Analysis: The confluence of Fibonacci levels within the buy zone enhances the probability of a reversal. Monitor price action closely as it approaches this zone. This is a swing trade setup with a medium to long-term timeframe.
NYSE:KOLong
by MrStockWhale
NTDOY Break Out incomingNintendo is poised to break out as there are numerous bullish events upcoming, 1. They just released a Pokemon trading card game app and it is addictive! All of my friends who are in their mid thirties have picked it up and are playing actively. Its a simple enough game for anyone to get into, but has alot of different strategies for people who are looking for a challenge. This game is going to print money. 2. The Switch 2 is right around the corner. As the Switch is almost the greatest selling system of all time, the Switch two is set up for immediate success. It is rumored to have backwards compatibility, so the Switch's already immense library give the system instant utility. Not to mention, it will be supported by world in class exclusives. The hard core Nintendo enthusiasts will pick this up day 1 and it will continue to dominate due to it's backwards compatibility and new features. 3. Nintendo is beginning to dominate media. The mario movie made 3x it's cost in the first month. It is also heavily rumored that a live action Zelda may be in the works. As Nintendo begins to explore this new avenue further, they may find success and unlock a brand new revenue stream by licensing their characters to media producers. 4. Nintendo is a digital distributor, meaning that traditional supply chain constraints only impact them at the base hardware level. Also, as we move more towards digital selves, companies that can sell art that is tied to culture or nostalgia, such as nintendo characters, are going to do very well. People will pay to use these characters to represent themselves.
OTC:NTDOYLong
by listo82
Starbucks (SBUX) - Long Setup On a ReversalWe're monitoring a potential bullish setup for Starbucks on the daily timeframe. The price is approaching a key buy zone, identified at the 0.618 - 0.786 Fibonacci levels, which aligns with previous structural support. This presents an opportunity for a reversal to the upside. Trade Details: - Entry (Buy Zone): $83.69 - Stop-loss (Red Zone): $76.79 Targets (Green Zones): - Target 1: $91.24 (0.382 retracement) - Target 2: $110.85 (0.236 retracement) Analysis: The bullish bias is supported by the confluence of Fibonacci retracement levels and the structural buy zone. Look for a bounce in this zone, with upside potential to the 0.382 and 0.236 retracement levels. This is a swing trade setup, so patience is key.
NASDAQ:SBUXLong
by MrStockWhale
ANF rocket fuel primed: Price Discovery ActivatedGreetings Everyone, I couldn’t delay sharing this exciting analysis on Abercrombie & Fitch (ANF), as it’s showing a significant technical setup that demands immediate attention. Supplementary Photos: www.dropbox.com 🌀 ANF’s Fourth Wave Triangle: What’s Unfolding? Abercrombie & Fitch is currently forming a classic 4th wave triangle as part of a larger Elliott Wave structure. Based on my analysis, it appears this consolidation phase has just completed, setting the stage for a potential breakout into the 5th wave. Here’s why this matters: 📈 Key Insights into ANF’s Wave Structure Fourth Wave Triangles in Elliott Wave Theory Fourth waves often manifest as contracting triangles—periods of lower volatility and sideways price action. These patterns serve as a pause in the trend before the final impulsive wave (Wave 5). ANF’s price action fits this structure perfectly, with decreasing volume during consolidation, a hallmark of Elliott Wave triangles. What’s Next? : If the triangle breakout is confirmed, I anticipate a strong 5th wave rally. Support and Resistance Zones The lower boundary of the triangle is providing robust support, while the breakout level near the upper resistance aligns with key Fibonacci retracement levels. Monitor for volume spikes as price approaches the breakout zone—this will validate the bullish move. Volume Dynamics Similar to what we’ve seen in past examples (like Chainlink’s accumulation breakout), volume during the breakout phase is crucial. ANF recently showed strong buying pressure near the triangle’s apex, indicating potential momentum. 📊 Strategy and Risk Management To maximize this opportunity, here are the key levels and strategies to consider: • Entry Point: A confirmed breakout above the triangle’s resistance with sustained volume. Stop-Loss: Place stops just below the triangle’s lower boundary to limit downside risk. Target: Based on Elliott Wave projections, the 5th wave could aim for 1.618 extension of Waves 1–3. Keep this level in focus as a profit-taking zone. Invalidation: A breakdown below the triangle would signal that the 4th wave correction is incomplete or that the larger wave structure is failing. Why This Setup is Important Abercrombie’s breakout would align with: • Broader market recovery trends. • Improved earnings performance (as seen in its Q3 highlights). • Continued strength in consumer spending and brand expansion efforts. Closing Thoughts This is a pivotal moment for ANF. With the completion of the 4th wave triangle
NYSE:ANFLong
by coilemard
2